Compare DSGR & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSGR | DBVT |
|---|---|---|
| Founded | 1952 | 2002 |
| Country | United States | France |
| Employees | N/A | 90 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1995 | 2014 |
| Metric | DSGR | DBVT |
|---|---|---|
| Price | $26.92 | $18.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $35.00 | $32.04 |
| AVG Volume (30 Days) | 58.4K | ★ 175.5K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 212.50 | 10.26 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,980,023,000.00 | $5,636,000.00 |
| Revenue This Year | $5.35 | $35.04 |
| Revenue Next Year | $3.79 | $2,360.78 |
| P/E Ratio | $2,694.00 | ★ N/A |
| Revenue Growth | 9.75 | ★ 35.77 |
| 52 Week Low | $19.02 | $7.53 |
| 52 Week High | $33.80 | $26.19 |
| Indicator | DSGR | DBVT |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 39.29 |
| Support Level | $26.94 | $16.49 |
| Resistance Level | $27.87 | $21.61 |
| Average True Range (ATR) | 0.54 | 0.85 |
| MACD | -0.08 | -0.09 |
| Stochastic Oscillator | 22.92 | 8.50 |
Distribution Solutions Group Inc is a specialty distribution company providing value-added distribution solutions to the maintenance, repair and operations (MRO), original equipment manufacturer (OEM) and industrial technology markets. The company operates through four reportable segments: Lawson, TestEquity, Gexpro Services and Canada Branch Division. Lawson distributes specialty products and services to the industrial, commercial, institutional and government MRO marketplace. TestEquity, which generates maximum revenue, distributes test and measurement equipment and solutions, industrial and electronic production supplies and vendor managed inventory programs. Gexpro Services is a supply chain solutions provider. The company generates majority of its revenue from United States.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.